hotspot -WSS

hotspot

author：comprehensive 2025-09-02 22:06:31 - browse：997

Chemotherapy infusion — The White House outlined its efforts to end shortages of three key generic chemotherapies. But experts want more more details. Gerry Broome/AP

WASHINGTON — The White House says it’s working to end shortages of three key generic chemotherapies. But experts said the administration would have to provide more details to fully mitigate the health care system’s concerns.

Carboplatin, cisplatin, and methotrexate are three of 15 cancer drugs in shortage in the United States. They have been staples of cancer treatment for decades, according to a White House blog post, but their supply in the United States has been nearly halved in the past year. The shortages have forced doctors to ration the drugs and alter treatment plans, leaving cancer patients to wonder whether their survival odds are hurt.

In its blog post, the White House noted that it’s now allowing Chinese imports of cisplatin. The Food and Drug Administration is also working with generic drug companies to boost production of all three drugs, but it didn’t say which companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： How to ethically and practically extend health care to all

WSS

Late stage cancers on the rise after pandemic delayed screenings

How I helped Pfizer think through the ethics of Viagra

Stanford president to resign after investigation of research

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

Plane’s emergency slide plummets from sky, hits Chicago home

Norman Reedus' Daryl Dixon

focus

hotspot

hotspot

Medical records are filled with copy

Medical experts are missing from AI regulatory conversations

Walensky prepares to leave CDC — and Congress — behind

Heart disease in astronauts blamed on cosmic radiation

Hepatitis C has a cure — but many Americans still lack access to it

The kidney, in all its complexity, is captured in a new atlas

Medical records are filled with copy

Why the Crimean Bridge is key to Russia's war in Ukraine

Peter Hotez and the public health issue of online harassment

Biotech startup Celsius cuts 75% of staff ahead of first trial start

hotspot

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

FDA scientists endorse Pfizer/BioNTech Covid

Alnylam reports growth in sales of rare disease treatments

Group behind ProMed defends move to subscription

Group behind ProMed defends move to subscription

Plane’s emergency slide plummets from sky, hits Chicago home

leisure time

entertainment

explore

focus